Cargando…

Safety of Topical Medications for Scabies and Lice in Pregnancy

Medications should be employed with caution in women of childbearing age. Topical medications have little systemic absorption. Therefore, they are considered safer than oral or parenteral agents and less likely to be embryotoxic or fetotoxic. However, their safety profile must be assessed cautiously...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Viral M, Lambert, W Clark, Schwartz, Robert A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122270/
https://www.ncbi.nlm.nih.gov/pubmed/27904173
http://dx.doi.org/10.4103/0019-5154.193659
_version_ 1782469545093496832
author Patel, Viral M
Lambert, W Clark
Schwartz, Robert A
author_facet Patel, Viral M
Lambert, W Clark
Schwartz, Robert A
author_sort Patel, Viral M
collection PubMed
description Medications should be employed with caution in women of childbearing age. Topical medications have little systemic absorption. Therefore, they are considered safer than oral or parenteral agents and less likely to be embryotoxic or fetotoxic. However, their safety profile must be assessed cautiously as the available data are limited. In this article, we aggregate human and animal studies to provide recommendations on using topical anti-scabies and anti-lice therapy in pregnancy.
format Online
Article
Text
id pubmed-5122270
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-51222702016-11-30 Safety of Topical Medications for Scabies and Lice in Pregnancy Patel, Viral M Lambert, W Clark Schwartz, Robert A Indian J Dermatol Review Article Medications should be employed with caution in women of childbearing age. Topical medications have little systemic absorption. Therefore, they are considered safer than oral or parenteral agents and less likely to be embryotoxic or fetotoxic. However, their safety profile must be assessed cautiously as the available data are limited. In this article, we aggregate human and animal studies to provide recommendations on using topical anti-scabies and anti-lice therapy in pregnancy. Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC5122270/ /pubmed/27904173 http://dx.doi.org/10.4103/0019-5154.193659 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Patel, Viral M
Lambert, W Clark
Schwartz, Robert A
Safety of Topical Medications for Scabies and Lice in Pregnancy
title Safety of Topical Medications for Scabies and Lice in Pregnancy
title_full Safety of Topical Medications for Scabies and Lice in Pregnancy
title_fullStr Safety of Topical Medications for Scabies and Lice in Pregnancy
title_full_unstemmed Safety of Topical Medications for Scabies and Lice in Pregnancy
title_short Safety of Topical Medications for Scabies and Lice in Pregnancy
title_sort safety of topical medications for scabies and lice in pregnancy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122270/
https://www.ncbi.nlm.nih.gov/pubmed/27904173
http://dx.doi.org/10.4103/0019-5154.193659
work_keys_str_mv AT patelviralm safetyoftopicalmedicationsforscabiesandliceinpregnancy
AT lambertwclark safetyoftopicalmedicationsforscabiesandliceinpregnancy
AT schwartzroberta safetyoftopicalmedicationsforscabiesandliceinpregnancy